Role of RPLND and Metastasectomy in the Management of Oligometastatic Renal Cell Carcinoma

Hellman S, Weichselbaum RR (1995) Oligometastases. J Clin Oncol 13(1):8–10. https://doi.org/10.1200/JCO.1995.13.1.8

Weichselbaum RR, Hellman S (2011) Oligometastases revisited. Nat Rev Clin Oncol 8(6):378–382. https://doi.org/10.1038/nrclinonc.2011.44

Paget S (1889) The distribution of secondary growths in cancer of the breast. Lancet 1:571–573

Chow WH, Devesa SS, Warren JL (1999) The rising incidence of renal cell carcinoma in the United States of America. JAMA 282:1629–1312

Motzer RJ, Bander NH, Nanus DM (1996) Renal cell carcinoma. N. Engl. J. Med 335(12):865–875

Bianchi M, Sun M, Jeldres C, Shariat SF, Trinh QD, Briganti A, Tian Z, Schmitges J, Graefen M, Perrotte P, Menon M, Montorsi F, Karakiewicz PI (2012) Distribution of metastatic sites in renal cell carcinoma: a population-based analysis. Ann Oncol 23(4):973–980. https://doi.org/10.1093/annonc/mdr362

Barney JD, Churchill EJ (1939) Adenocarcinoma of the kidney with metastasis to the lung. J Urol 42(3):269–276. https://doi.org/10.1016/S0022-5347(17)71516-9

Piltz S, Meimarakis G, Wichmann MW, Hatz R, Schildberg FW, Fuerst H (2002) Long term results after pulmonary resection of renal cell carcinoma metastasis. Ann Thorac Surg 73(4):1082–1087. https://doi.org/10.1016/S0003-4975(01)03602-5

Friedel G, Hürtgen M, Penzenstadler M, Kyriss T, Toomes H (1999) Resection of pulmonary metastases from renal cell carcinoma. Anticancer Res 19:1593–1596

Pfannschmidt J, Hoffmann H, Krysa S, Trainer C, Dienemann H (2002) Prognostic factors for survival after pulmonary resection of metastatic renal cell carcinoma. Ann Thorac Surg 74(5):1653–1657. https://doi.org/10.1016/S0003-4975(02)03803-1

Cerfolio RJ, Allen MS, Deschamps C, Daly RC, Wallrichs SL, Trastek VF, Pairolero PC (1994) Pulmonary resection of metastatic renal cell carcinoma. Ann Thorac Surg 57(2):339–344. https://doi.org/10.1016/0003-4975(94)90994-6

Zekri J, Ahmed N, Coleman RE, Hancock BW (2001) The skeletal metastatic complications of renal cell carcinoma. Int. J. Oncol 19(2):379–382

Jung ST, Ghert MA, Harrelson JM, Scully SP (2003) Treatment of osseous metastasis in patients with renal cell carcinoma. Clin Orthop Relat Res 409:223–231. https://doi.org/10.1097/01.blo.0000059580.08469.3e

Alves A, Adam R, Majno P, Delvart V, Azoulay D, Castaong D, Bismuth H (2003) Hepatic resection for metastatic renal tumors: is it worthwhile? Ann Surg Oncol 10(6):705–710. https://doi.org/10.1245/ASO.2003.07.024

Suppiah R, Shaheen PE, Elson P et al (2006) Thrombocytosis as a prognostic factor for survival in patients with metastatic renal cell carcinoma. Cancer 107(8):1793–1800

Ruys AT, Tanis PJ, Iris ND, van Duijvendijk P, Verhoef C, Porte RJ, van Gulik TM (2011) Surgical treatment of renal cell cancer liver metastasis: a population based study. Ann Surg Oncol 18(7):1932–1938. https://doi.org/10.1245/s10434-010-1526-x

McKay RR, Kroeger N, Xie W, Lee JL, Knox JJ, Bjarnason GA, MacKenzie MJ, Wood L, Srinivas S, Vaishampayan UN, Rha SY, Pal SK, Donskov F, Tantravahi SK, Rini BI, Heng DY, Choueiri TK (2014) Impact of bone and liver metastases on patients with renal cell carcinoma treated with targeted therapy. Eur Urol 65(3):577–584. https://doi.org/10.1016/j.eururo.2013.08.012

Bennington JL (1973) Proceedings: cancer of the kidney-etiology, epidemiology and pathology. Cancer 32(5):1017–1029. https://doi.org/10.1002/1097-0142(197311)32:5<1017::AID-CNCR2820320501>3.0.CO;2-Z

Ballarin R, Spaggiari M, Cautero N, Deruvo N, Montalti R, Longo C et al (2011) Pancreatic metastasis from renal cell carcinoma: the state of the art. World J Gastroenterol 17(43):4747–4756. https://doi.org/10.3748/wjg.v17.i43.4747

Yuasa T, Inoshita N, Saiura A, Yamamoto S, Urakami S, Masuda H, Fujii Y, Fukui I, Ishikawa Y, Yonese J (2015) Clinical outcome of patients with pancreatic metastases from renal cell cancer. BMC Cancer 15(1):46. https://doi.org/10.1186/s12885-015-1050-2

Bianchi M, Sun M, Jeldres C (2012) Distribution of metastatic sites in renal cell carcinoma: a population-based analysis. Ann Oncol 23(4):973–980. https://doi.org/10.1093/annonc/mdr362

Tsui KH, Shvarts O, Barbaric Z (2000) Is adrenalectomy a necessary component of radical nephrectomy? UCLA experience with 511 radical nephrectomies. J Urol 163(2):437–441. https://doi.org/10.1016/S0022-5347(05)67895-0

Kuczyk M, Munch T, Machtens S (2002) The need for routine adrenalectomy during surgical treatment for renal cell cancer: the Hannover experience. BJU Int 89(6):517–522. https://doi.org/10.1046/j.1464-410X.2002.02671.x

Saitoh H, Nakayama M, Nakamura K, Satoh T (1982) Distant metastasis of renal adenocarcinoma in nephrectomized cases. J Urol 127(6):1092–1095. https://doi.org/10.1016/S0022-5347(17)54243-3

Mortensen H (1948) Transthoracic nephrectomy. J Urol 60(6):855–858. https://doi.org/10.1016/S0022-5347(17)69315-7

Breau RH, Allmer C, Lohse CM, Cheville JC, Leibovich BC, Blute ML (2011) Lymph node dissection at the time of radical nephrectomy for high risk clear cell renal cell carcinoma: indications and recommendations for surgical templates. Eur Urol 59(1):18–23. Crispen PL

Robson CJ, Churchill BM, Anderson W (1969) The results of radical nephrectomy for renal cell carcinoma. J Urol 101(3):297–301. https://doi.org/10.1016/S0022-5347(17)62331-0

Parker AE (1935) Studies on the main posterior lymph channels of the abdomen and their connections with the lymphatic’s of the genito-urinary system. Am J Anat 56(3):409–443. https://doi.org/10.1002/aja.1000560305

Herrlinger A, Schrott KM, Schott G, Sigel A (1991) What are the benefits of extended dissection of the regional renal lymph nodes in the therapy of renal cell carcinoma. J Urol 146(5):1224–1227. https://doi.org/10.1016/S0022-5347(17)38052-7

Whitson JM, Harris CR, Reese AC et al (2011) Lymphadenectomy improves survival of patients with renal cell carcinoma and nodal metastasis. J Urol 185:1615–1620

Delacroix SE Jr, Chapin BF, Chen JJ et al (2011) Can a durable disease-free survival be achieved with surgical resection in patients with pathological node positive renal cell carcinoma? J Urol 186:1236–1241

Blute ML, Leibovich BC, Cheville JC et al A protocol for performing extended lymph node dissection using primary tumor pathological features for patients treated with radical nephrectomy for clear cell renal cell carcinoma. J Urol 172(2):465–469

Terrone C, Guercio S, De Luca S et al The number of lymph nodes examined and staging accuracy in renal cell carcinoma. BJU Int 91(1):37–40

Blom JHM, van Poppel H, Marechal JM et al (2009) Radical nephrectomy with and without lymph-node dissection: final results of European Organization for Research and Treatment of Cancer (EORTC) randomized phase 3 trial 30881. Eur Urol 55(1):28–34. https://doi.org/10.1016/j.eururo.2008.09.052